Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Introduction to Epidemiology01:26

Introduction to Epidemiology

742
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
742
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

266
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
266
Pharmacovigilance01:19

Pharmacovigilance

850
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
850
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

1.2K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
1.2K
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

476
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
476

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

COVID-19 and pregnancy: A European study on pre- and post-infection medication use.

European journal of clinical pharmacology·2024
Same author

The Need for the Closer Monitoring of Novel Drugs in MS: A Siponimod Retrospective Cohort Study (Realhes Study).

Journal of clinical medicine·2023
Same author

Medical Students' Opinion of Their Learning Process.

Medical science educator·2023
Same author

Spontaneous Reporting of Adverse Drug Reactions in a Pediatric Population in a Tertiary Hospital.

Journal of clinical medicine·2021
Same author

Drug-Related Deaths in a Tertiary Hospital: Characteristics of Spontaneously Reported Cases and Comparison to Cases Detected from a Retrospective Study.

Journal of clinical medicine·2021
Same author

Epidemiology of drug-related deaths in European hospitals: A systematic review and meta-analysis of observational studies.

British journal of clinical pharmacology·2021

Related Experiment Video

Updated: Jul 10, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

Pharmacoepidemiology: An Overview.

Mònica Sabaté1,2, Eva Montané2,3

  • 1Department of Clinical Pharmacology, Hospital Universitari Vall d'Hebron, Clinical Pharmacology Research Group, Vall d'Hebron Research Institute, 08035 Barcelona, Spain.

Journal of Clinical Medicine
|November 25, 2023
PubMed
Summary

Pharmacoepidemiology is crucial for understanding real-world drug safety and effectiveness beyond clinical trials. This review covers its methods, trends, and the role of real-world evidence in healthcare and policy.

Keywords:
adverse drug reactiondrug safetyeffectivenesspatient safetypharmacoepidemiologypharmacovigilanceregulatory decision

More Related Videos

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K
Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
12:34

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

834

Related Experiment Videos

Last Updated: Jul 10, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.8K
Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
12:34

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

834

Area of Science:

  • Pharmacoepidemiology
  • Real-world evidence
  • Drug safety and effectiveness

Background:

  • Randomized clinical trials (RCTs) have limitations in reflecting real-world drug outcomes.
  • Healthcare professionals and regulatory bodies require robust data on drug safety and effectiveness in large populations.
  • Pharmacoepidemiologic research is essential for informing evidence-based medicine and public health policy.

Purpose of the Study:

  • To provide a comprehensive overview of pharmacoepidemiology, including its definition, scope, and methodologies.
  • To discuss future trends, new methods for bias and confounding, and the integration of real-world evidence into drug development.
  • To offer recommendations for clinicians engaging in pharmacoepidemiologic research.

Main Methods:

  • Review of study designs and methodologies in pharmacoepidemiology.
  • Discussion of emerging trends and advanced techniques for bias and confounding mitigation.
  • Exploration of artificial intelligence applications in real-world data management.

Main Results:

  • Highlights the necessity of pharmacoepidemiologic studies for real-world drug assessment.
  • Summarizes key aspects for conducting and interpreting pharmacoepidemiologic research.
  • Reports on new methodologies and initiatives for generating valid real-world evidence.

Conclusions:

  • Pharmacoepidemiology bridges the gap between clinical trial data and real-world drug performance.
  • The field is evolving with new methodologies and the integration of artificial intelligence.
  • This review serves as a guide for researchers and clinicians in pharmacoepidemiologic studies.